Frontiers in Cellular and Infection Microbiology (May 2024)
Plasmodium vivax spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections
- Alberto Ayllon-Hermida,
- Alberto Ayllon-Hermida,
- Alberto Ayllon-Hermida,
- Marc Nicolau-Fernandez,
- Marc Nicolau-Fernandez,
- Ane M. Larrinaga,
- Iris Aparici-Herraiz,
- Iris Aparici-Herraiz,
- Elisabet Tintó-Font,
- Oriol Llorà-Batlle,
- Agnes Orban,
- María Fernanda Yasnot,
- Mariona Graupera,
- Mariona Graupera,
- Mariona Graupera,
- Manel Esteller,
- Manel Esteller,
- Manel Esteller,
- Manel Esteller,
- Jean Popovici,
- Jean Popovici,
- Alfred Cortés,
- Alfred Cortés,
- Hernando A. del Portillo,
- Hernando A. del Portillo,
- Hernando A. del Portillo,
- Carmen Fernandez-Becerra,
- Carmen Fernandez-Becerra,
- Carmen Fernandez-Becerra
Affiliations
- Alberto Ayllon-Hermida
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Alberto Ayllon-Hermida
- IGTP Institut d’Investigació Germans Trias i Pujol, Ctra. de Can Ruti, Barcelona, Spain
- Alberto Ayllon-Hermida
- School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
- Marc Nicolau-Fernandez
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Marc Nicolau-Fernandez
- IGTP Institut d’Investigació Germans Trias i Pujol, Ctra. de Can Ruti, Barcelona, Spain
- Ane M. Larrinaga
- Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain
- Iris Aparici-Herraiz
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Iris Aparici-Herraiz
- IGTP Institut d’Investigació Germans Trias i Pujol, Ctra. de Can Ruti, Barcelona, Spain
- Elisabet Tintó-Font
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Oriol Llorà-Batlle
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Agnes Orban
- Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia
- María Fernanda Yasnot
- Grupo de Investigaciones Microbiológicas y Biomédicas de Córdoba-GIMBIC, Universidad de Córdoba, Monteria, Colombia
- Mariona Graupera
- Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain
- Mariona Graupera
- ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
- Mariona Graupera
- CIBERONC, Centro de Investigacion Biomedica en Red Cancer, Instituto de Salud Carlos III, Madrid, Spain
- Manel Esteller
- ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
- Manel Esteller
- CIBERONC, Centro de Investigacion Biomedica en Red Cancer, Instituto de Salud Carlos III, Madrid, Spain
- Manel Esteller
- Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain
- Manel Esteller
- 0Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain
- Jean Popovici
- Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia
- Jean Popovici
- 1G5 Épidémiologie et Analyse des Maladies Infectieuses, Département de Santé Globale, Institut Pasteur, Paris, France
- Alfred Cortés
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Alfred Cortés
- ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
- Hernando A. del Portillo
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Hernando A. del Portillo
- IGTP Institut d’Investigació Germans Trias i Pujol, Ctra. de Can Ruti, Barcelona, Spain
- Hernando A. del Portillo
- ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
- Carmen Fernandez-Becerra
- ISGlobal, Barcelona Institute for Global Health, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
- Carmen Fernandez-Becerra
- IGTP Institut d’Investigació Germans Trias i Pujol, Ctra. de Can Ruti, Barcelona, Spain
- Carmen Fernandez-Becerra
- 2CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- DOI
- https://doi.org/10.3389/fcimb.2024.1408451
- Journal volume & issue
-
Vol. 14
Abstract
Recent studies indicate that human spleen contains over 95% of the total parasite biomass during chronic asymptomatic infections caused by Plasmodium vivax. Previous studies have demonstrated that extracellular vesicles (EVs) secreted from infected reticulocytes facilitate binding to human spleen fibroblasts (hSFs) and identified parasite genes whose expression was dependent on an intact spleen. Here, we characterize the P. vivax spleen-dependent hypothetical gene (PVX_114580). Using CRISPR/Cas9, PVX_114580 was integrated into P. falciparum 3D7 genome and expressed during asexual stages. Immunofluorescence analysis demonstrated that the protein, which we named P. vivax Spleen-Dependent Protein 1 (PvSDP1), was located at the surface of infected red blood cells in the transgenic line and this localization was later confirmed in natural infections. Plasma-derived EVs from P. vivax-infected individuals (PvEVs) significantly increased cytoadherence of 3D7_PvSDP1 transgenic line to hSFs and this binding was inhibited by anti-PvSDP1 antibodies. Single-cell RNAseq of PvEVs-treated hSFs revealed increased expression of adhesion-related genes. These findings demonstrate the importance of parasite spleen-dependent genes and EVs from natural infections in the formation of intrasplenic niches in P. vivax, a major challenge for malaria elimination.
Keywords
- Plasmodium vivax
- intrasplenic infections
- extracellular vesicles (EVs)
- CRISPR/Ca9
- single-cell RNASeq (scRNASeq)
- spleen fibroblasts